These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 462847)

  • 1. [Use of hormone loading tests for assessing the source of hyperestrogenism and the functional state of the ovaries in breast cancer patients in menopause].
    Bogdanova AG; Mezinova NN
    Vopr Onkol; 1979; 25(5):20-3. PubMed ID: 462847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is the hyperestrogenism of endometrial cancer of ovarian or adrenal origin?].
    Hustin J; Buret J
    Bull Soc R Belge Gynecol Obstet; 1967; 37(5):405-13. PubMed ID: 5606212
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma testosterone in idiopathic hirsutism, and the changes produced by adrenal and ovarian stimulation and suppression.
    Casey JH; Nabarro JD
    J Clin Endocrinol Metab; 1967 Oct; 27(10):1431-5. PubMed ID: 4293667
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the urinary excretion, biological effects and origin of oestrogens in post-menopausal women.
    Procopé BJ
    Acta Endocrinol (Copenh); 1968; 60 Suppl 135():5-110. PubMed ID: 4309973
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenal function in early and metastatic breast cancer: dexamethasone suppression of plasma cortisol.
    Drafta DS; Stroe E; Schindler EE; Teodosiu T; Gozariu L; Drafta D
    Endocrinologie; 1981; 19(2):115-21. PubMed ID: 6789444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens in breast cancer. III. Breast cancer recurrences years after mastectomy and increased androgenic activity.
    Grattarola R; Secreto G; Recchione C
    Am J Obstet Gynecol; 1975 Jan; 121(2):169-72. PubMed ID: 1115123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients.
    Rose DP; Davis TE
    Cancer Res; 1980 Nov; 40(11):4043-7. PubMed ID: 6451282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current concept of the hormonal state in menopause].
    Salvadori B
    Minerva Ginecol; 1975 Oct; 27(10):792-4. PubMed ID: 1228502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature of ovarian-adrenal dysfunction in breast cancer patients.
    Kodama M; Kodama T; Miura S; Yoshida M; Takagi H; Totani R; Ooki T
    J Natl Cancer Inst; 1979 Sep; 63(3):599-608. PubMed ID: 288926
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the immunological reactivity and hormonal profile in patients with breast cancer].
    Baisheva SA; Bogdanova AG
    Vopr Onkol; 1984; 30(12):19-23. PubMed ID: 6516268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of the dexamethasone-mestranol-HCG test for the differential diagnosis of forms of hirsutism].
    Wodrig W; Kother T
    Zentralbl Gynakol; 1985; 107(14):883-8. PubMed ID: 4036406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The urinary excretion of estrogens in patients with far advanced breast cancer during treatment with prednisolone].
    Konoplia EF
    Vopr Onkol; 1968; 14(12):12-8. PubMed ID: 5714178
    [No Abstract]   [Full Text] [Related]  

  • 13. The genesis of breast cancer is a two-step phenomenon. II. Dissociation of two biomarkers in cancer patients from a low risk area of Japan.
    Kodama M; Kodama T; Murakami M; Kobayashi S; Akita T; Nakamura Y
    Anticancer Res; 1992; 12(1):153-60. PubMed ID: 1567162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The importance of studying steroid and hypophyseal hormone excretion in patients with dyshormonal tumors].
    Sharoukhova KS
    Vestn Akad Med Nauk SSSR; 1968; 23(3):63-8. PubMed ID: 5754742
    [No Abstract]   [Full Text] [Related]  

  • 15. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of hormonal patterns in breast neoplasms. Physiopathologic and clinical considerations].
    Giordano G; Cacciari P
    Arch Sci Med (Torino); 1968 Oct; 125(10):525-35. PubMed ID: 5735716
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine function in premenopausal and postmenopausal advanced breast cancer patients treated with CMF or tamoxifen.
    Bhatavdekar JM; Shah NG; Patel DD; Karelia NH; Trivedi SN; Vora HH; Ghosh N; Giri DD; Balar DB
    Neoplasma; 1992; 39(2):123-7. PubMed ID: 1528310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virilization in pregnancy associated with polycystic ovary disease.
    Fayez JA; Bunch TR; Miller GL
    Obstet Gynecol; 1974 Oct; 44(4):511-21. PubMed ID: 4370552
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclic ovarian function and breast cancer.
    Sherman BM; Wallace RB; Bean JA
    Cancer Res; 1982 Aug; 42(8 Suppl):3286s-3288s. PubMed ID: 7083188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.